| Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248) |
|---|
| 01/16/2002 | EP0603386B1 Parenteral immunization against rotavirus |
| 01/16/2002 | EP0496875B1 METHODS FOR PRODUCING RNA VIRUSES FROM cDNA |
| 01/16/2002 | CN1331745A Gene and proteins, and their use |
| 01/16/2002 | CN1331699A Methods of identifying antigen gene sequences |
| 01/16/2002 | CN1331604A Compsn. consisting of influenza virus surface proteins and dispensing device |
| 01/16/2002 | CN1331603A Tolerance to xenograft |
| 01/16/2002 | CN1331602A Methods of downmodulating immune response to therapeutic proteins |
| 01/16/2002 | CN1331558A Orally immunogenic bacterial enterotoxins expressed in transgenic plants |
| 01/16/2002 | CN1077801C Carcinoembryonic antigen gene engineering antibody CL-3-scFv |
| 01/15/2002 | US6339149 Isolated nucleic acid molecules which encode tumor rejection antigens found in dage |
| 01/15/2002 | US6339070 Gene directed enzyme prodrug therapy (gdept) using in situ antibody generation to provide enhanced selectivity, in cancer therapy; for delivering cytotoxic drugs |
| 01/15/2002 | US6339068 Vectors and methods for immunization or therapeutic protocols |
| 01/15/2002 | US6338952 Stress proteins and uses therefor |
| 01/15/2002 | US6338950 DNA encoding LST-1 protein and process for recombinant production of LST-1 protein |
| 01/15/2002 | US6338853 Cell surface antigens from human cancer and cultures |
| 01/15/2002 | US6338852 Compounds and methods for diagnosis of tuberculosis |
| 01/15/2002 | US6338851 Method of suppressing an immune response to a transplanted organ or tissue by administering an OX-2 protein |
| 01/15/2002 | US6338850 Administering immunosuppressive dosage of plant tissue and purification |
| 01/15/2002 | US6338849 Process of preparing immunoglobulin for intravenous injection by viruses double-sterilized without adding any protectant |
| 01/15/2002 | US6338848 Treating multiple sclerosis with immunoglobulins and interleukins |
| 01/15/2002 | US6338845 Tumor killing effects of enterotoxins, superantigens, and related compounds |
| 01/15/2002 | US6338835 Radioprotectant for peptides labeled with radioisotope |
| 01/15/2002 | CA2118724C Detection method for c-raf-1 genes |
| 01/15/2002 | CA2109304C Glycosylated prodrugs, and their processes of preparation and use |
| 01/15/2002 | CA2030951C Process for producing immunostimulant agents |
| 01/10/2002 | WO2002002801A1 Method of assaying the function of fc fragment of antibody |
| 01/10/2002 | WO2002002797A2 Regulation of human 11 beta-hydroxysteroid dehydrogenase 1-like enzyme |
| 01/10/2002 | WO2002002781A1 Heterodimeric fusion proteins |
| 01/10/2002 | WO2002002780A2 Human serine-threonine kinase |
| 01/10/2002 | WO2002002775A2 Calpain protease 12 |
| 01/10/2002 | WO2002002773A2 Dual specificity antibodies and methods of making and using |
| 01/10/2002 | WO2002002772A2 Human extracellular matrix (ecm)-related tumor marker |
| 01/10/2002 | WO2002002752A1 Attenuated bovine respiratory syncytial virus |
| 01/10/2002 | WO2002002751A2 Alteration of cell membrane |
| 01/10/2002 | WO2002002744A2 Dna encoding a human melanin concentrating hormone receptor (mch1) and uses thereof |
| 01/10/2002 | WO2002002642A2 Composition for pharmaceutical and cosmetic products |
| 01/10/2002 | WO2002002640A2 Antibodies to human mcp-1 |
| 01/10/2002 | WO2002002639A2 Human ion channels |
| 01/10/2002 | WO2002002625A2 Novel fibroblast growth factors and nucleic acids encoding same |
| 01/10/2002 | WO2002002623A2 Compositions and methods for the therapy and diagnosis of lung cancer |
| 01/10/2002 | WO2002002619A1 The t-cell protein (tzon7), peptides and antibodies derived therefrom and uses thereof |
| 01/10/2002 | WO2002002606A2 Immunisation against chlamydia pneumoniae |
| 01/10/2002 | WO2002002605A2 Attenuated human-bovine chimeric parainfluenza virus (piv) vaccines |
| 01/10/2002 | WO2002002587A1 B7-like polynucleotides, polypeptides, and antibodies |
| 01/10/2002 | WO2002002143A2 Enhancement of antibody-cytokine fusion protein mediated immune responses by combined treatment with immunocytokine uptake enhancing agents |
| 01/10/2002 | WO2002002141A2 Vaccine against helicobacter pylori |
| 01/10/2002 | WO2002002140A1 Vaccine comprising active agent immunogenic acyl glyceryl phosphatidylinositol manno-oligosaccharide |
| 01/10/2002 | WO2002002139A2 Methods and composition for oral vaccination |
| 01/10/2002 | WO2002002137A2 Contraceptive vaccines for pest control |
| 01/10/2002 | WO2002002131A2 Compositions and methods for the diagnosis and treatment of herpes simplex virus infection |
| 01/10/2002 | WO2002002011A1 Dna encoding human serine protease d-g |
| 01/10/2002 | WO2001074164A9 Methods of modulating hair growth |
| 01/10/2002 | WO2001070775A3 Wnt-1 related polypeptides, and nucleic acids encoding the same |
| 01/10/2002 | WO2001060404A3 Use of opri lipoprotein from pseudomonas as a th1 inducing natural adjuvant for heterologous antigens |
| 01/10/2002 | WO2001056611B1 Oral delivery of allergens in milk |
| 01/10/2002 | WO2001053349A3 Small cell lung cancer associated antigens and uses therefor |
| 01/10/2002 | WO2001045730A3 Tweak receptor |
| 01/10/2002 | WO2001045639A3 Methods for protecting against lethal infection with bacillus anthracis |
| 01/10/2002 | WO2001044289A3 Modified leukotoxin gene and protein |
| 01/10/2002 | WO2001042444A3 Methods for expression of genes in primates |
| 01/10/2002 | WO2001042438A3 Leukolysin/mmp25/mt6-mmp |
| 01/10/2002 | WO2001040449A3 Cloning of a gene encoding an amino acid racemase from trypanosoma cruzi, and uses thereof |
| 01/10/2002 | WO2001040279A3 Hbv sequences |
| 01/10/2002 | WO2001040276A3 Serpentine transmembrane antigens expressed in human prostate cancers and uses thereof |
| 01/10/2002 | WO2001040270A3 A major neutralization site of hepatitis e virus and use of this neutralization site in methods of vaccination and in methods of screening for neutralizing antibodies |
| 01/10/2002 | WO2001038358A3 Hbv/hcv virus-like particle |
| 01/10/2002 | WO2001036472A3 Compositions and methods for regulating tumor-associated antigen expression |
| 01/10/2002 | WO2001036452A3 Heteroclitic analogs of class i epitodes |
| 01/10/2002 | WO2001035810A3 Cancer immunotherapy and diagnosis using cytochrome p450 1b1 |
| 01/10/2002 | WO2001029217A3 Novel polypeptides and polynucleotides encoding same |
| 01/10/2002 | WO2001012664A3 Notch receptor ligands and uses thereof |
| 01/10/2002 | WO2001000829A3 Human endogenous retrovirus in breast cancer |
| 01/10/2002 | WO2000066162A9 Mutant human cd80 and compositions for and methods of making and using the same |
| 01/10/2002 | US20020004587 Antibody for use in the treatment of cancer; antitumor agents |
| 01/10/2002 | US20020004585 Antibody for use in the detection of preferential enzyme expression; for use as tool in treatment and detection of enzyme defects; for treatment autoimmune disease, inflammation, sepsis, diabetes, kidney defects and cancer |
| 01/10/2002 | US20020004580 Polypeptide; for use in the diagnosis and treatment of microorganismal infections; bactericides |
| 01/10/2002 | US20020004531 Nitrone inhibition of cancer development |
| 01/10/2002 | US20020004482 Treatment of acute lung injury and fibrosis with antagonists of avbeta6 |
| 01/10/2002 | US20020004236 27960, a novel ubiquitin conjugating enzyme family member and uses therefor |
| 01/10/2002 | US20020004208 Generating nicotine antibodies in situ |
| 01/10/2002 | US20020004077 Antioxidant compositions extracted from olives and olive by-products |
| 01/10/2002 | US20020004076 Oral immunology using plant product containing a non-enteric pathogen antigen |
| 01/10/2002 | US20020004058 Immunomodulating and antiinflammatory agent |
| 01/10/2002 | US20020004053 Identifying a cellular/acellular organism site on living body and combining administration of adjuvant which increases immune response (builds antibodies) and photodynamic light causing necrosis |
| 01/10/2002 | US20020004052 Composition comprising a tumor cell extract and method of using the composition |
| 01/10/2002 | US20020004051 Materials and methods for prevention or reduction of the severity of heartwater |
| 01/10/2002 | US20020004050 For use in the prevention of influenza Haemophilus influenzae and/or Streptococcus pneumoniae virus infections; synergistic; for sublingual/nasal administration |
| 01/10/2002 | US20020004048 Hepatitis C virus asialoglycoproteins |
| 01/10/2002 | US20020004047 DNA encoding a novel RG1 polypeptide |
| 01/10/2002 | US20020004046 Includes use of neutralizing antibody, high affinity antibodies, and viricide (ribavirin, amantadine, rimantadine, or a neuraminidase inhibitor); useful for controlling/treating respiratory syncytial virus in young children |
| 01/10/2002 | US20020004044 Methods for inducing the differentiation of monocytes into functional dendritic cells |
| 01/10/2002 | US20020004041 Inducing tolerance in mammals to antigen via isolating peripheral blood mononuclear cells, then isolating dendritic cells and exposing to apoptotic cells in absence of cell surface glycoprotein receptors for HIV; prophylaxis |
| 01/10/2002 | DE10128980A1 Genetically modified T cells, useful e.g. for inhibiting allogenic transplant rejection, produced by incubating recipient and donor T cells then transducing with immunomodulatory gene |
| 01/10/2002 | DE10031932A1 Calpain-Protease 12 Calpain protease 12 |
| 01/10/2002 | CA2630062A1 Methods for treating graft versus host disease and immune disorders associated with rejection using a soluble ctla4 molecule |
| 01/10/2002 | CA2585012A1 Antibodies that immunospecifically bind to blys |
| 01/10/2002 | CA2415123A1 Novel fibroblast growth factors and nucleic acids encoding same |
| 01/10/2002 | CA2414884A1 Immunisation against chlamydia pneumoniae |
| 01/10/2002 | CA2414672A1 Novel human serine-threonine kinase |
| 01/10/2002 | CA2414596A1 Compositions and methods for the therapy and diagnosis of lung cancer |